F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

OBI Pharma, Inc. engages in the development and licensing of novel therapeutic agents for unmet medical needs against cancer. Its products include Adagloxad Simolenin, which is a late-stage novel active immune-oncology Globo Series-based therapeutic vaccine for the treatment of epithelial cancers, such as breast, ovarian, lung, prostate, colon, gastric, and pancreatic cancer. The company was founded by Michael N. Chang on April 29, 2002 and is headquartered in Taipei, Taiwan.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Scancell is developing therapeutic vaccines for the treatment of cancer and infectious diseases based on its ImmunoBody® and Moditope™ technology platforms. Scancell’s first cancer vaccine SCIB1 is being developed for the treatment of melanoma and is in Phase 1/2 clinical trials. Preliminary evidence from Part 1 of the study showing that SCIB1 produced an immune response which might be associated with clinical benefit in patients with malignant melanoma was released in December 2012.

Shenzhen Guochuang Nanobody Technology Co., Ltd., established on 2016-03-07, Business scope includes general business items:biomedical products;Monoclonal antibody product and technology development;Nanobody product and technology development;Biotechnology,Research and Development of Nanotechnology;Import and export;medical instruments,Research and development of consumables,Sales,Technical Services,technology transfer.(law,Except for items prohibited by administrative regulations;law,Projects restricted by administrative regulations must be licensed before they can be operated),The licensing program is:Health Supplies(Does not contain health food)promotion of.

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Accelerated Biosciences Corp. is a private company headquartered in the United States that provides regenerative medicine company.

San Diego-based company with manufacturing facilities in Irvine, Calif. and Paris, France.

Chongqing Precision Biotechnology Co., Ltd. is a private company headquartered in Chongqing, China, that provides research and development biotechnology services.

Henan Shengsheng Medical Equipment Co., Ltd., established on 2011-11-11, Business scope includes general items:Sales of Class I Medical Devices;Sales of Class II Medical Devices;Class I Medical Device Leasing;Class II Medical Device Leasing;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Information Technology Consulting Services;software development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Wholesale;Cosmetics Retail;General merchandise sales;Daily necessities wholesale;Sales of agricultural and sideline products;Disinfectant sales(Free of Hazardous Chemicals);Home Appliance Sales;Office Supplies Sales;Sales of office equipment consumables;Office Equipment Sales;electronics sales;Instrument sales;housing lease;Experimental analysis instrument sales;Smart Instrument Sales;Teaching equipment sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shanghai Liangrun Biomedical Technology Co., Ltd., established on 2013-09-09, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:engaged in biotechnology,Medical Technology,medical instruments,Technology development in the field of medical technology expertise,Technical Services,technology transfer,technical consulting,Technology Promotion,Technology Exchange,Production of Class I Medical Devices,Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals),First,Class II medical device,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Instrumentation,plastic products,Fiberglass and its products,High-performance non-ferrous metals and alloy materials,Sales of packaging materials and products,Engaged in the import and export of goods and technology,Re-export trade,Trade and trade agency for enterprises in the region.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Suzhou Proda Biotechnology Co., Ltd., established on 2012-12-22, Business scope includes biomedicine,Health products,food,cosmetic,medical instruments,Non-hazardous chemical products,Research and development of sewage treatment technology,Technical cooperation,technical consulting,technology transfer;Sales:Non-hazardous chemical products,Class I medical device,cosmetic.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

BioMerieux designs, develops, manufactures, and markets in vitro diagnostic systems for clinical and industrial applications. The company’s diagnostic systems consist of reagents and consumables used to conduct biological tests, for use in performing screening, diagnostic assistance, prognosis, and treatment monitoring; instruments, platforms, and autoanalyzers used for automated testing at high or low throughputs; software to process analyses and systems to interpret biological test results; and other related services such as the installation and maintenance of instruments, user training, and the audit of laboratory workflows. BioMerieux offers diagnostic systems for clinical applications including the diagnosis of infectious diseases, comprising HIV, tuberculosis, and respiratory diseases, as well as cardiovascular diseases and targeted cancers based on the analysis of biological samples such as blood, saliva, and urine; and for industrial applications including the analysis of microbiological manufacturing such as food, pharmaceuticals, and cosmetics. The company markets and sells its products through a network of distributors to private sector analysis laboratories, hospital laboratories, blood banks, and physician office laboratories; food, pharmaceutical, and cosmetics industries; and independent quality control laboratories. It has operations in Europe, the Middle East, Africa, North America, Asia-Pacific, and Latin America. BioMerieux were founded in 1963 and is headquartered in Marcy l’Etoile, France. It is a subsidiary of Institut Mérieux.

Szybio is engaged in the research and development, production, and sales of in vitro diagnostic reagents for clinical medicine. Their products and services include biochemical diagnostic reagent products, molecular diagnostic reagents, diagnostic testing-related equipment focusing on latex-enhanced immune turbidimetric technology products, and more.

Tianjin East Asia Biotechnology Co., Ltd., established on 2010-03-24, Business scope includes research on biomedical technology,to develop,Transfer and its technical services;Business Information Consulting Service.The country has a franchise,The special provisions shall be handled according to the special provisions of the franchise.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Sanjian Biotechnology Co., Ltd., established on 2009-04-09, Business scope includes research and development of antibodies and other biological reagents,Production,sales and export(non-clinical use);and related technical services;Ikind,IIkind,IIIResearch and development of quasi-in vitro diagnostic reagents,Production,Sales(Subject to the medical device production and operation license)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangzhou Xiangsheng Intelligent Technology Co., Ltd., established on 2017-11-17, Business scope includes medical diagnosis,Monitoring and treatment equipment wholesale;Licensed medical device business;medical diagnosis,Monitoring and treatment equipment retail;Medical Data Management and Analysis;robot sales;Robotic System Sales;robotics research,technology development;Robotic system technical service;Operation of non-licensed medical devices;Medical supplies and equipment retail(Does not contain drugs and medical devices);Medical equipment rental service;Medical technology research and development;Medical technology promotion service;Medical Technology Consulting,communication service;Medical technology transfer service;Research and development of biological products(Does not include licensed operations);Biomedical Technology Research;Research and development of biodiagnostic reagents and kits(Does not include license approval items);Biotechnology Extension Services;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Commodity wholesale trade(Except for licensed and approved products);Internet Merchandise Sales(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);Internet commodity retail(Except for licensed and approved products);Import and export(Excluding franchised products);Technology Import and Export;Computer Network System Engineering Services;computer wholesale;Wholesale of computer spare parts;computer retail;Computer Parts Retail;Computer and communication equipment rental;computer technology development,Technical Services;Computer Information Security Product Design;Information system integration service;Information Technology Consulting Services;Information Electronic Technology Services;Network information technology promotion service;Information System Security Services;Network Security Information Consulting;Science and Technology Information Consulting Services;Research on Network Technology,to develop;Technology intermediary service;Technology project agency service;Technology project bidding service;Science and technology project evaluation service;Scientific and technological achievements appraisal service;

Beijing Leadman Biochemistry Co., Ltd (hereinafter referred to as: Leadman) was founded in November 1997. It is a high-tech enterprise focusing on R & D, manufacture, and sales of in vitro diagnostic (IVD) products. Equipped with international management concept, innovative R & D team, high-quality products, nationwide marketing network, and excellent technical services, Leadman has become a highly diversified enterprise with core competencies in biochemistry, in vitro diagnostic reagents and instruments. In December 2013, Leadman moved to its new headquarter base in BDA, Beijing. This complex consists of parts: production, R&D, and office and recreation area. The total construction area is about 100,000 square meters. Leadman R & D Centre includes Instrument Research Division, Diagnostic Reagents Research Division and Biochemical Raw Materials Research Division. This superb R & D team, 95 percent of which have bachelor degree and above, 46 percent of which have master's or doctoral degree, has invented and generated numerous innovative products and intellectual properties.Leadman Manufacturing Center includes biochemical diagnostic reagents production division and instrument production division. Leadman has imported four sophisticated production lines from VETRACO, Italy, consolidating the formulating, distributing, labeling, capping and packaging, temperature regulated storing steps into a fully automated process. After the upgrade, the capacity of reagents production is increased to 4000 liters per day. The General Quality Laboratory, the 'heart' of the Leadman manufacture process to deliver the most reliable products, consists of the state-of-the-art Reference Laboratory, QA and QC. Leadman truly believes excellent quality is the root and life of its products in the market. Leadman exceeded in the Quality Management System Assessments conducted by Beijing Food and Drug Administration, and was accredited with YY/T 0287 idt IOS 13458:2003 and GB/T19001 idt ISO 9001:2008 Quality Management System Certifications. Comprehensive quality management system, high end production equipment, innovative R& D team, efficient quality control measures and standardized production operating procedures, ensure the best product quality. Today, Leadman has established one wholly-owned subsidiary and over 200 distributors spread around China. The nationwide network ensures Leadman have an insight into market trends and immediately response to customers' demands. 'A promise for a better life' is Leadman's motto. Leadman is to devote itself to this unlimited vision, to establish itself as the most reliable and influential life science company in China.